share_log

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

Benzinga ·  May 10 13:33

B of A Securities analyst Alec Stranahan upgrades Novavax (NASDAQ:NVAX) from Underperform to Neutral and raises the price target from $4 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment